Lupus nephritis (LN) is present in approximately 25% to 50% of patients at the time of systemic lupus erythematosus diagnosis and eventually develops in up to 60% of adults and 80% of children.¹ Over the past 5 decades, major advances in immunosuppressive medications for patients with severe LN (classes III, IV, and V alone or in combination) have resulted in significant improvements in patient survival.².

中文翻译：

---

狼疮性肾炎的治疗策略。

系统性红斑狼疮诊断时，约 25% 至 50% 的患者患有狼疮性肾炎 (LN)，最终在高达 60% 的成人和 80% 的儿童中出现狼疮性肾炎 (LN)。¹过去 5 年来，针对严重 LN（单独或联合使用 III、IV 和 V 类）患者的免疫抑制药物治疗取得了重大进展，显着改善了患者的生存率。² .